Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

Roche

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.

Roche

Roche’s Soliris rival Enspryng bags FDA approval

Roche’s Soliris rival Enspryng bags FDA approval The new NMOSD treatment was originally designed by Roche’s Japanese subsidiary Chugai, using novel recycling antibody technology. ... Roche has already submitted regulatory filings for the drug with the European Medicines Agency (EMA) and China’s

AbbVie, Roche’s Venclyxto combo reduces risk of death in first-line AML

AbbVie, Roche’s Venclyxto combo reduces risk of death in first-line AML AbbVie and Roche have announced the publication of results from the phase 3 VIALE-A trial of Venclyxto in patients with acute myeloid leukaemia (AML) in the New England Journal of ... 2020. AbbVie sells the drug on its own outside the US, while Roche’s

Roche scores FDA approval for SMA drug risdiplam, now named Evrysdi

Roche scores FDA approval for SMA drug risdiplam, now named Evrysdi Drug poised to challenge rivals Spinraza and Zolgensma. Roche has won approval from the US Food and Drug Administration (FDA) for its spinal muscular atrophy (SMA) drug risdiplam under the brand ... Roche has priced Evrysdi by patient weight, with a

Tecentriq combo fails in advanced triple negative breast cancer

Tecentriq combo fails in advanced triple negative breast cancer Roche plans to discuss the full results from the study with global health authorities and will be presented at an undisclosed future medical meeting. ... TNBC is an important niche for Roche’s checkpoint inhibitor, in a class that is otherwise

Novartis builds its case for novel MS treatment ofatumumab

Novartis builds its case for novel MS treatment ofatumumab The MS market has long been dominated by Roche’s blockbuster drug Ocrevus (ocrelizumab), which is used in both relapsing forms of MS and primary progressive MS, although it is facing

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics